Exelixis
EXEL
#1726
Rank
NZ$16.81 B
Marketcap
$58.88
Share price
-1.16%
Change (1 day)
54.82%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company